학술논문
188P IPH5201 as monotherapy or in combination with durvalumab (D) in advanced solid tumours
Document Type
Abstract
Author
Source
In Immuno-Oncology and Technology December 2022 16 Supplement 1
Subject
Language
ISSN
2590-0188